A novel SAMD9 mutation causing MIRAGE syndrome: An expansion and review of phenotype, dysmorphology, and natural history
- PMID: 29266745
- DOI: 10.1002/ajmg.a.38557
A novel SAMD9 mutation causing MIRAGE syndrome: An expansion and review of phenotype, dysmorphology, and natural history
Abstract
Germline gain-of-function variants in SAMD9 have been associated with a high risk of mortality and a newly recognized constellation of symptoms described by the acronym MIRAGE: Myelodysplasia, Infection, Restriction of growth, Adrenal insufficiency, Genital phenotypes, and Enteropathy. Here, we describe two additional patients currently living with the syndrome, including one patient with a novel de novo variant for which we provide functional data supporting its pathogenicity. We discuss features of dysmorphology, contrasting with previously described patients as well as drawing attention to additional clinical features, dysautonomia and hearing loss that have not previously been reported. We detail both patients' courses following diagnosis, with attention to treatment plans and recommended specialist care. Our patients are the oldest known with arginine-substituting amino acid variants, and we conclude that early diagnosis and multidisciplinary management may positively impact outcomes for this vulnerable group of patients.
Keywords: MIRAGE syndrome; SAMD9; adrenal insufficiency; myelodysplasia.
© 2017 Wiley Periodicals, Inc.
Similar articles
-
Emerging phenotypes linked to variants in SAMD9 and MIRAGE syndrome.Front Endocrinol (Lausanne). 2022 Aug 18;13:953707. doi: 10.3389/fendo.2022.953707. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36060959 Free PMC article.
-
SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7.Nat Genet. 2016 Jul;48(7):792-7. doi: 10.1038/ng.3569. Epub 2016 May 16. Nat Genet. 2016. PMID: 27182967
-
Two patients with MIRAGE syndrome lacking haematological features: role of somatic second-site reversion SAMD9 mutations.J Med Genet. 2018 Feb;55(2):81-85. doi: 10.1136/jmedgenet-2017-105020. Epub 2017 Nov 24. J Med Genet. 2018. PMID: 29175836
-
A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases.Pediatr Blood Cancer. 2019 Jul;66(7):e27726. doi: 10.1002/pbc.27726. Epub 2019 Mar 21. Pediatr Blood Cancer. 2019. PMID: 30900330 Review.
-
SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.Leukemia. 2018 May;32(5):1106-1115. doi: 10.1038/s41375-018-0074-4. Epub 2018 Feb 25. Leukemia. 2018. PMID: 29535429 Free PMC article. Review.
Cited by
-
Emerging phenotypes linked to variants in SAMD9 and MIRAGE syndrome.Front Endocrinol (Lausanne). 2022 Aug 18;13:953707. doi: 10.3389/fendo.2022.953707. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36060959 Free PMC article.
-
A girl with MIRAGE syndrome who developed steroid-resistant nephrotic syndrome: a case report.BMC Nephrol. 2020 Aug 12;21(1):340. doi: 10.1186/s12882-020-02011-4. BMC Nephrol. 2020. PMID: 32787808 Free PMC article.
-
Reversion SAMD9 Mutations Modifying Phenotypic Expression of MIRAGE Syndrome and Allowing Inheritance in a Usually de novo Disorder.Front Endocrinol (Lausanne). 2019 Sep 11;10:625. doi: 10.3389/fendo.2019.00625. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31572304 Free PMC article.
-
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes.Nat Med. 2021 Oct;27(10):1806-1817. doi: 10.1038/s41591-021-01511-6. Epub 2021 Oct 7. Nat Med. 2021. PMID: 34621053 Free PMC article.
-
Neutropenia in the age of genetic testing: Advances and challenges.Am J Hematol. 2019 Mar;94(3):384-393. doi: 10.1002/ajh.25374. Epub 2019 Jan 8. Am J Hematol. 2019. PMID: 30536760 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical